CTLA4 and metastatic melanoma: In this study, we searched and analyzed four available human datasets with RNA-seq data and clinical information from metastatic melanoma patients treated with anti-PD-1, anti-PD-L1, anti-CTLA-4 monotherapy, or a combination of any two.